HKSE:02291 (China)
Â
Class H
HK$
24.45
+2.55 (+11.64%)
Apr 25
What is a stock summary page? Click here for an overview.
Business Description
Lepu Scientech Medical Technology (Shanghai) Co Ltd
ISIN : CNE1000057M5
Share Class Description:
HKSE:02291: Class HCompare
Compare
Traded in other countries / regions
02291.Hong Kong Index Membership
Hong Kong Stock Connect IPO Date
2022-11-08Description
Lepu Scientech Medical Technology (Shanghai) Co Ltd is focused on the research and development, manufacture, and commercialization of heart disease interventional medical devices.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 743.54 | |||||
| Equity-to-Asset | 0.96 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 1600.36 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 51.29 | |||||
| Beneish M-Score | -0.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22.7 | |||||
| 3-Year EBITDA Growth Rate | 42.1 | |||||
| 3-Year EPS without NRI Growth Rate | 55.6 | |||||
| 3-Year FCF Growth Rate | 107.8 | |||||
| 3-Year Book Growth Rate | 65.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.35 | |||||
| 9-Day RSI | 68.18 | |||||
| 14-Day RSI | 65.63 | |||||
| 3-1 Month Momentum % | 5.59 | |||||
| 6-1 Month Momentum % | -4.39 | |||||
| 12-1 Month Momentum % | -23.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 16.79 | |||||
| Quick Ratio | 15.76 | |||||
| Cash Ratio | 13.33 | |||||
| Days Inventory | 590.5 | |||||
| Days Sales Outstanding | 45.62 | |||||
| Days Payable | 161.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.86 | |||||
| Dividend Payout Ratio | 0.78 | |||||
| Forward Dividend Yield % | 2.83 | |||||
| 5-Year Yield-on-Cost % | 2.77 | |||||
| Shareholder Yield % | 3.12 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 89.91 | |||||
| Operating Margin % | 55.69 | |||||
| Net Margin % | 52.08 | |||||
| FCF Margin % | 29.06 | |||||
| ROE % | 12.61 | |||||
| ROA % | 11.78 | |||||
| ROIC % | 29.97 | |||||
| 3-Year ROIIC % | -54.61 | |||||
| ROC (Joel Greenblatt) % | 132.92 | |||||
| ROCE % | 14.69 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 32.13 | |||||
| Forward PE Ratio | 21.46 | |||||
| PE Ratio without NRI | 31.35 | |||||
| Price-to-Owner-Earnings | 41.17 | |||||
| PEG Ratio | 1.28 | |||||
| PS Ratio | 16.76 | |||||
| PB Ratio | 3.98 | |||||
| Price-to-Tangible-Book | 4.67 | |||||
| Price-to-Free-Cash-Flow | 57.67 | |||||
| Price-to-Operating-Cash-Flow | 35.59 | |||||
| EV-to-EBIT | 20.85 | |||||
| EV-to-EBITDA | 20.71 | |||||
| EV-to-Revenue | 12.66 | |||||
| EV-to-FCF | 39.52 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.29 | |||||
| Price-to-Graham-Number | 2.55 | |||||
| Price-to-Net-Current-Asset-Value | 5.96 | |||||
| Price-to-Net-Cash | 7.64 | |||||
| Earnings Yield (Greenblatt) % | 4.8 | |||||
| FCF Yield % | 1.73 | |||||
| Forward Rate of Return (Yacktman) % | 20.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lepu Scientech Medical Technology (Shanghai) Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 505.77 | ||
| EPS (TTM) (HK$) | 0.761 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 42.92 | ||
| 14-Day RSI | 65.63 | ||
| 14-Day ATR (HK$) | 2.000161 | ||
| 20-Day SMA (HK$) | 16.7895 | ||
| 12-1 Month Momentum % | -23.6 | ||
| 52-Week Range (HK$) | 13 - 27.2 | ||
| Shares Outstanding (Mil) | 346.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lepu Scientech Medical Technology (Shanghai) Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lepu Scientech Medical Technology (Shanghai) Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lepu Scientech Medical Technology (Shanghai) Co Ltd Frequently Asked Questions
What is Lepu Scientech Medical Technology (Shanghai) Co Ltd(HKSE:02291)'s stock price today?
The current price of HKSE:02291 is HK$24.45. The 52 week high of HKSE:02291 is HK$27.20 and 52 week low is HK$13.00.
When is next earnings date of Lepu Scientech Medical Technology (Shanghai) Co Ltd(HKSE:02291)?
The next earnings date of Lepu Scientech Medical Technology (Shanghai) Co Ltd(HKSE:02291) is .
Does Lepu Scientech Medical Technology (Shanghai) Co Ltd(HKSE:02291) pay dividends? If so, how much?
The Dividend Yield %  of Lepu Scientech Medical Technology (Shanghai) Co Ltd(HKSE:02291) is 2.86% (As of Today), Highest Dividend Payout Ratio of Lepu Scientech Medical Technology (Shanghai) Co Ltd(HKSE:02291) was 0.78. The lowest was 0.78. And the median was 0.78. The  Forward Dividend Yield % of Lepu Scientech Medical Technology (Shanghai) Co Ltd(HKSE:02291) is 2.83%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers